🔴 Moleculin Biotech is trading 6.21% down today with no confirmed catalyst identified

Moleculin Biotech is trading at $0.65, down 6.21%, with no confirmed company-specific catalyst identified.

• No new company-specific announcement dated September 3, 2026 was identified; the decline appears isolated.
• Biotech sentiment is broadly positive, with XBI up 1.21% during the session.
• Recent trial and financing updates, including the July 31, 2026 offering and MIRACLE data, are earlier; volume and activity details were unavailable.